348 related articles for article (PubMed ID: 38200564)
1. Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier.
Colón Ortiz R; Knerler S; Fridman LB; Mercado A; Price AS; Rosado-Franco JJ; Wilkins H; Flores BR; Orsburn BC; Williams DW
Fluids Barriers CNS; 2024 Jan; 21(1):5. PubMed ID: 38200564
[TBL] [Abstract][Full Text] [Related]
2. Cocaine Regulates Antiretroviral Therapy CNS Access Through Pregnane-X Receptor-Mediated Drug Transporter and Metabolizing Enzyme Modulation at the Blood Brain Barrier.
Fridman LB; Knerler S; Price AS; Ortiz RC; Mercado A; Wilkins H; Flores BR; Orsburn BC; Williams DW
bioRxiv; 2023 Jul; ():. PubMed ID: 37546800
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
4. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
Harati R; Villégier AS; Banks WA; Mabondzo A
J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
[TBL] [Abstract][Full Text] [Related]
6. Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood-brain barrier.
Lye P; Bloise E; Matthews SG
Fluids Barriers CNS; 2023 Jan; 20(1):8. PubMed ID: 36721242
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model.
Ghosh C; Hossain M; Mishra S; Khan S; Gonzalez-Martinez J; Marchi N; Janigro D; Bingaman W; Najm I
Epilepsia; 2018 Nov; 59(11):2049-2060. PubMed ID: 30264400
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.
Huang Y; Hoque MT; Jenabian MA; Vyboh K; Whyte SK; Sheehan NL; Brassard P; Bélanger M; Chomont N; Fletcher CV; Routy JP; Bendayan R
J Antimicrob Chemother; 2016 Jul; 71(7):1954-65. PubMed ID: 27076103
[TBL] [Abstract][Full Text] [Related]
9. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection.
Eng ME; Imperio GE; Bloise E; Matthews SG
Cell Mol Life Sci; 2022 Jul; 79(8):415. PubMed ID: 35821142
[TBL] [Abstract][Full Text] [Related]
10. Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2).
Nicolazzo JA; Katneni K
Curr Top Med Chem; 2009; 9(2):130-47. PubMed ID: 19200001
[TBL] [Abstract][Full Text] [Related]
11. Physical and Metabolic Integrity of the Blood-Brain Barrier in HIV Infection: A Special Focus on Intercellular Junctions, Influx and Efflux Transporters and Metabolizing Enzymes.
Shawahna R
Curr Drug Metab; 2015; 16(2):105-23. PubMed ID: 26179607
[TBL] [Abstract][Full Text] [Related]
12. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
14. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.
Pal D; Kwatra D; Minocha M; Paturi DK; Budda B; Mitra AK
Life Sci; 2011 May; 88(21-22):959-71. PubMed ID: 20932495
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
Zhang W; Oh JH; Zhang W; Rathi S; Larson JD; Wechsler-Reya RJ; Sirianni RW; Elmquist WF
J Pharmacol Exp Ther; 2023 Dec; 387(3):315-327. PubMed ID: 37827699
[TBL] [Abstract][Full Text] [Related]
18. Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.
Zolotoff C; Voirin AC; Puech C; Roche F; Perek N
Cell Physiol Biochem; 2020 Dec; 54(6):1231-1248. PubMed ID: 33326735
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
20. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.
Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A
Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
